CLINICAL TRIAL PROTOCOL 
A Phase [ADDRESS_340985]-Operative Pain 
Protocol Number: 
Protocol Amendment l Date: 
Protocol Version: 
Investigational Product: 
IND Number: 
Sponsor: 
Principal Investigator: [INVESTIGATOR_279363]002-16-092/ [STUDY_ID_REMOVED]
[ADDRESS_340986] 
Chandler, AZ [ZIP_CODE] 
Medical Monitor: , MD 
Insys Development Company, Inc. 
 
Phone:  
Fax:  
Confidentiality Statement 
This study will be performed in compliance with Good Clinical Practices (GCP) and applicable regulatory 
requirements. The confidential information in this document is provided to you as an investigator, 
potential investigator or consultant for review by [CONTACT_10825], your staff and applicable Independent Ethics 
Committee (IEC) or Institutional Review Board (IRB). It is understood that the information will not be 
disclosed to others without written authorization from Insys Development Company, Inc., except to the 
extent necessary to obtain informed consent from those persons to whom the drug may be administered. 
